Physician profile
Luis Cadena
NPI 1518340371
$880.38
in general payments reported to CMS, 2019-2025
19 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.69 · 2022: $243 · 2023: $92.64 · 2024: $125 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $157.48 | 2021-2024 | Orthovisc |
| Stryker Corporation | $115.05 | 2022-2025 | Insignia, Mako |
| Convatec INC. | $91.37 | 2025 | |
| Bioventus LLC | $78.15 | 2021-2025 | Durolane |
| Vertex Pharmaceuticals Incorporated | $71.14 | 2025 | |
| Boston Scientific Corporation | $57.44 | 2022 | |
| Amgen INC. | $49.01 | 2022-2024 | Prolia, Evenity |
| Horizon Therapeutics Plc | $41.20 | 2022 | |
| Fidia Pharma USA INC. | $38.30 | 2024-2025 | Hymovis |
| Molnlycke Health Care US, LLC | $32.51 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Biotissue Holdings INC. | $24.74 | 2024 | |
| Ferring Pharmaceuticals INC. | $22.48 | 2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $21.31 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Pfizer INC. | $20.00 | 2021 | |
| Heron Therapeutics, INC. | $19.85 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $15.34 | 2025 | Physio-Stim |
| Solventum Corporation | $13.46 | 2024 | Prevena, V.A.C.Ulta |
| Ethicon US, LLC | $6.84 | 2022 | |
| Heraeus Medical, LLC. | $4.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Cadena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.